PPARβ/δ was found significantly reduced in a small series of HCC with respect to the surrounding nontumoral tissue and the PPARβ/δ agonist GW501516 suppressed CyclinD1 expression and cell proliferation in Hepa1-6 cells [115]. The gene discussed is PPARD; the disease is hepatocellular carcinoma.